The mechanism of action of 3‐hydroxy‐3‐methylglutaryl‐CoA reductase solubilized from rat liver microsomes has been investigated. In the reduction of 3‐hydroxy‐3‐methylglutaryl‐CoA to mevalonate, an overall initial velocity study gave a linear intersecting pattern when both 3‐hydroxy‐3‐methylglutaryl‐CoA and NADPH were variable substrates. Adenosine 2′‐monophospho‐5′‐diphos‐phoribose, which was found to be a reversible inhibitor of reductase, inhibited the enzyme competitively with respect to NADPH, and uncompetitively with respect to 3‐hydroxy‐3‐methylglutaryl‐CoA. On the other hand, the inhibition of reductase by ML‐236B (sodium salt), a specific reversible inhibitor of the enzyme isolated from the culture of a Penicillium (whose structure is given in the paper) is competitive with respect to 3‐hydroxy‐3‐methylglutaryl‐CoA and noncompetitive with respect to NADPH [Endo et al. (1976) FEBS Lett. 72 , 323–3261. The reduction of 3‐hydroxy‐3‐methylglutaryl‐CoA to mevalonate was subject to the substrate inhibition by NADPH attributed to the formation of a productive enzyme‐NADPH complex. These results indicate that the two substrates bind to the enzyme effectively in an ordered manner; reductase first interacts with 3‐hydroxy‐3‐methylglutaryl‐CoA to make a binary complex, which, in turn, forms a ternary complex with one molecule of NADPH. Considered together with the results of product inhibition study, and assuming a hemithioacetal of mevaldate and CoA is an intermediate of the reductase reaction, a bi‐uni‐uni‐ter‐ping‐pong mechanism is proposed as a model of the overall reaction.
No takes yet. Share an insight, caveat, or question.
Tanzawa et al. (1979) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: